Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLM.L Regulatory News (RLM)

  • There is currently no data for RLM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealing

12 Aug 2014 11:49

RNS Number : 9031O
PuriCore Plc
12 August 2014
 



Director Dealing

 

12 August 2014 - PuriCore plc (LSE: PURI) (the "Company"), a global company focused on safe and effective protection against the spread of infectious pathogens, today announces a director dealing, in accordance with the Disclosure and Transparency Rules. On 11 August 2014, the following Director notified the Company that he had purchased ordinary shares of 10p each in the share capital of the Company ("Shares"), as set out below.

 

 

Name

Date Purchased

Number of Shares Purchased

Purchase Price of Shares

Shareholding following the Acquisition

Percentage of Issued Share Capital

Michael Ashton (CEO)

Michael Ashton (CEO)

11 August 2014

11 August 2014

50,000

100,000

35p

39p

Total Dealing

150,000

169,350

0.34%

 

 

Enquiries:

UK

US

FTI Consulting

Sage Strategic Marketing

Mo Noonan/Simon Conway

Jennifer Guinan

Victoria Foster Mitchell

+1 610.410.8111

+44 203 727 1000

jennifer@sagestrat.com

 

 

About PuriCore

PuriCore plc (LSE: PURI) is a global company focused on safe and effective protection against the spread of infectious pathogens without causing harm to human or animal health or to the environment. PuriCore's antimicrobial technology and complementary products are used in a well-established core business and emerging sectors of two broad markets: Food & Agriculture and Health Sciences. In the Food & Agriculture market, PuriCore's portfolio is used by thousands of US supermarket retailers, including three of the top-five, to provide savings in labour costs and improvements in inventory loss and to address cross contamination of pathogens on fresh produce and floral products. In the Health Sciences market, PuriCore's breakthrough wound care technology is used to treat chronic and acute wounds including diabetic ulcers and burns in humans, for atopic dermatitis as private-labelled dermatologic treatments for humans, and to manage wounds in all species of companion and farm animals in the animal health segment. PuriCore is headquartered in Malvern, Pennsylvania. To receive additional information on PuriCore, visit www.puricore.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGGUQCRUPCGUP
Date   Source Headline
11th Jun 20072:32 pmRNSPresenting at Conference
11th Jun 200712:18 pmRNSHolding(s) in Company
31st May 200710:14 amRNSResult of AGM
23rd May 200712:00 pmBUSFDA Lists Sterilox Food Safety Solution for Food Contact
23rd May 20077:02 amRNSRe: Food Safety Solution
21st May 200712:00 pmBUSStudy Shows PuriCore's Aquatine(TM) EC Effective for Root Canal Disinfecting and Cleansing
14th May 20075:57 pmRNSAnnual Information Update
25th Apr 20079:14 amRNSDirector/PDMR Shareholding
19th Apr 200710:45 amRNSHolding(s) in Company
19th Apr 20079:54 amRNSDirector/PDMR Shareholding
18th Apr 20074:00 pmRNSHolding(s) in Company
18th Apr 20077:01 amRNSDirector/PDMR Shareholding
16th Apr 20077:02 amRNSFinal Results
5th Apr 200712:00 pmBUSPuriCore Receives FDA 510(k) Approval for Endoscope Disinfectant System in US
5th Apr 20077:01 amRNSFDA 510(k) Approval
29th Mar 20078:00 amRNSNotice of Results
27th Mar 20071:54 pmBUSPuriCore signs additional endoscope reprocessor marketing partnership
27th Mar 20071:02 pmRNSSigns Marketing Partnership
5th Mar 20075:12 pmRNSHolding(s) in Company
5th Feb 20077:01 amRNSRe Agreement
5th Feb 20077:01 amRNSTrading Update
26th Jan 20073:44 pmRNSRe: Section 198
8th Jan 20077:00 amRNSFundraising
18th Dec 20064:01 pmRNSTransparency Rule
8th Dec 20062:00 pmRNSGreg Bosch Wins CEO of Year
13th Nov 20067:02 amRNSAppointment
7th Nov 20063:47 pmRNSRe Interest in Shares
7th Nov 20063:44 pmRNSInterest in Shares
13th Sep 20067:03 amRNSAppointments
13th Sep 20067:03 amRNSContract
13th Sep 20067:03 amRNSInterim Results
21st Aug 200611:05 amRNSHolding(s) in Company
16th Aug 200611:12 amRNSNotice of Results
7th Aug 20063:43 pmRNSBlocklisting Applications

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.